About
Technology
Issues
FAQ
Search
filter by year
2024 (41)
2023 (1,025)
2022 (4,703)
Similar Keywords
national institute (81,244)
1-20 of (5,769 documents found)
2022
384
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
Nature
(
27.8
★★★
), 603, 687-692.
Cite
Citations
Matthew Li (80, 6.9K)
2022
356
Homologous and Heterologous Covid-19 Booster Vaccinations
New England Journal of Medicine
(
27.0
★★★
), 386, 1046-1057.
Cite
Citations
Matthew Li (80, 6.9K)
2022
743
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
Lancet, The
(
13.7
★★★
), 399, 1303-1312.
Cite
Citations
Matthew Li (80, 6.9K)
2022
471
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study
Lancet, The
(
13.7
★★★
), 399, 1618-1624.
Cite
Citations
Matthew Li (80, 6.9K)
2022
92
Defining the risk of SARS-CoV-2 variants on immune protection
Nature
(
27.8
★★★
), 605, 640-652.
Cite
Citations
Matthew Li (80, 6.9K)
2022
85
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age
New England Journal of Medicine
(
27.0
★★★
), 386, 2011-2023.
Cite
Citations
Matthew Li (80, 6.9K)
2022
479
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Lancet Infectious Diseases, The
(
9.1
★★★
), 22, 183-195.
Cite
Citations
Matthew Li (80, 6.9K)
2022
332
Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis
Lancet Respiratory Medicine,the
(
10.7
★★★
), 10, 447-458.
Cite
Citations
Matthew Li (80, 6.9K)
2022
250
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Lancet, The
(
13.7
★★★
), 399, 665-676.
Cite
Citations
Matthew Li (80, 6.9K)
2023
182
Introducing the Bacterial and Viral Bioinformatics Resource Center (BV-BRC): a resource combining PATRIC, IRD and ViPR
Nucleic Acids Research
(
14.5
★★★
), 51, D678-D689.
Cite
Citations
Matthew Li (80, 6.9K)
2022
52
Cemented or Uncemented Hemiarthroplasty for Intracapsular Hip Fracture
New England Journal of Medicine
(
27.0
★★★
), 386, 521-530.
Cite
Citations
Matthew Li (80, 6.9K)
2022
183
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Lancet, The
(
13.7
★★★
), 399, 143-151.
Cite
Citations
Matthew Li (80, 6.9K)
2022
166
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
Lancet, The
(
13.7
★★★
), 399, 1779-1789.
Cite
Citations
Matthew Li (80, 6.9K)
2022
340
ESHRE guideline: endometriosis
Human Reproduction Open
(
5.4
★★★
), 2022, hoac009.
Cite
Citations
Matthew Li (80, 6.9K)
2022
146
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
Lancet, The
(
13.7
★★★
), 399, 36-49.
Cite
Citations
Matthew Li (80, 6.9K)
2022
170
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
Lancet Respiratory Medicine,the
(
10.7
★★★
), 10, 761-775.
Cite
Citations
Matthew Li (80, 6.9K)
2022
133
Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study
Lancet, The
(
13.7
★★★
), 399, 359-371.
Cite
Citations
Matthew Li (80, 6.9K)
2022
123
AI recognition of patient race in medical imaging: a modelling study
The Lancet Digital Health
(
12.3
★★★
), 4, e406-e414.
Cite
Citations
Matthew Li (80, 6.9K)
2022
142
Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study
Lancet Diabetes and Endocrinology,the
(
11.4
★★★
), 10, 253-263.
Cite
Citations
Matthew Li (80, 6.9K)
2022
170
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study
Lancet Infectious Diseases, The
(
9.1
★★★
), 22, 1002-1010.
Cite
Citations
Matthew Li (80, 6.9K)
1
2
3
site/software ©
exaly
; All materials licenced under
CC by-SA
.